| Organism name | Aeschynanthus bracteatus | 
|---|---|
| Genus | Aeschynanthus | 
| Family | Gesneriaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Aeschynanthus bracteatus | 
|---|---|
| Linked NCBI taxonomy ID | 175969 | 
| Linked level | species | 
| Family in NCBI taxonomy | Gesneriaceae | 
|---|---|
| ID | 26122 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | asterids | 
|---|---|
| ID | 71274 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00014028   | Corymboside / 6-alpha-L-Arabinopyranosyl-8-beta-D-galactopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | No. 1 | No. 15 |   | ||||
| C00000982   | Naringenin / (-)-Naringenin | CHEMBL9352 CHEMBL32571 | C005273 | 57 / 46 / 40 | 35 / 10 | No. 25 | No. 14 |   | 
| C00033616   | Aeschynanthoside D / (-)-Aeschynanthoside D | No. 33 |   | |||||
| C00033687   | Calceolarioside E | No. 33 |   | |||||
| C00033615   | Aeschynanthoside C / (-)-Aeschynanthoside C | No. 33 |   | |||||
| C00033613   | Aeschynanthoside A / (-)-Aeschynanthoside A | No. 33 |   | |||||
| C00002783   | Kusaginin / Acteoside / Verbascoside | CHEMBL231853 CHEMBL444478 CHEMBL1364101 | C058956 | 12 / 1 / 1 | 34 / 3 | No. 33 |   | |
| C00033958   | Isonuomioside A | No. 33 |   | |||||
| C00033614   | Aeschynanthoside B / (-)-Aeschynanthoside B | No. 33 |   | |||||
| C00033950   | Icariol A2 / (-)-Icariol A2 | CHEMBL466534 | No. 38 | No. 21 |   | |||
| C00033556   | 3,4-Dihydroxyphenethyl glucoside / (-)-3,4-Dihydroxyphenethyl glucoside | CHEMBL1689261 | 1 / 0 / 3 | No. 45 | No. 72 |   | ||
| C00034184   | Pyrroside B | No. 48 | No. 14 |   | ||||
| C00033567   | 4-Epipinfaensin / 4-epi-Pinfaensin | No. 50 | No. 51 |   | ||||
| C00034098   | Paradrymonoside / (+)-Paradrymonoside | No. 50 | No. 51 |   | ||||
| C00034295   | Suavissimoside F1 / (-)-Suavissimoside F1 | No. 50 | No. 51 |   | ||||
| C00000631   | trans-Dihydrodehydrodiconiferyl alcohol-9-O-beta-D-glucoside | CHEMBL466931 | No. 193 |   | ||||
| C00033622   | Alaschanioside C | CHEMBL1086907 | No. 193 |   | ||||
| C00033656   | Balanophonin / (-)-Balanophonin | CHEMBL253335 CHEMBL468666 CHEMBL590760 CHEMBL1956166 | No. 215 | No. 23 |   | |||
| C00006091   | Hemiphloin / 6-C-Glucosylnaringenin / (S)-6-beta-D-Glucopyranosyl-4',5,7-trihydroxyflavanone / (2S)-6-beta-D-Glucopyranosyl-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | CHEMBL562199 CHEMBL1645374 | C066406 | No. 261 | No. 14 |   | ||
| C00000614   | Coniferyl alcohol | CHEMBL501870 CHEMBL2088631 | C010559 | No. 310 | No. 6 |   | ||
| C00031384   | Sinapinaldehyde | CHEMBL225067 | No. 310 | No. 6 |   | |||
| C00002728   | Coniferaldehyde / Coniferyl aldehyde / 4-Hydroxy-3-methoxycinnamaldehyde | CHEMBL242529 CHEMBL1956165 | C075384 | 1 / 1 / 1 | No. 310 | No. 6 |   | |
| C00033554   | 2-Methoxy-4-(3-methoxy-1-propenyl)-phenol | No. 310 | No. 6 |   | ||||
| C00034298   | Syringenin | CHEMBL1800816 | No. 310 | No. 6 |   | |||
| C00033685   | Calceolarioside A | CHEMBL481635 | C083066 | 1 / 0 / 0 | No. 382 |   | ||
| C00033686   | Calceolarioside B | CHEMBL518414 | 3 / 2 / 5 | No. 382 |   | |||
| C00034207   | Sanangoside | No. 382 |   | |||||
| C00006430   | Ormocarpin | No. 521 |   | |||||
| C00033999   | Koaburaside | CHEMBL513117 | 2 / 4 / 2 | No. 678 | No. 6 |   | ||
| C00000856   | 4-Hydroxybenzoic acid / p-Hydroxybenzoic acid | CHEMBL441343 | C038193 | 21 / 7 / 16 | 2 / 1 | No. 817 | No. 81 |   | 
| C00007558   | Syringaldehyde / 4-Hydroxy-3,5-dimethoxybenzaldehyde | CHEMBL225303 | C069665 | No. 856 |   | |||
| C00029961   | Cinnamic acid / .beta-Phenylacrylic acid | CHEMBL27246 | C029010 | 5 / 2 / 2 | 16 / 2 | No. 904 | No. 6 |   | 
| C00002683   | Vanillin | CHEMBL13883 | 18 / 8 / 9 | No. 1003 |   | |||
| C00029479   | Veratric acid / 3,4-dimethoxybenzoic acid | CHEMBL118903 | C009333 | 10 / 6 / 6 | No. 1073 |   | ||
| C00033516   | 1,3-Dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propan-2-one | No. 1180 |   | |||||
| C00002743   | Ferulic acid / 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid | CHEMBL32749 | C004999 | 110 / 52 / 40 | 16 / 6 | No. 1366 | No. 6 |   | 
| C00033897   | Guaiacylglycerol-beta-ferulic acid ether | No. 1504 |   | |||||
| C00033510   | 1-(2-Hydroxy-5-methoxyphenyl)-1,2-propanediol | No. 1736 |   | |||||
| C00033837   | Ethylparaben | CHEMBL15841 | C012313 | 11 / 10 / 9 | 4 / 1 | No. 2169 |   | |
| C00033844   | Evofolin B / (-)-Evofolin B | CHEMBL448601 CHEMBL602133 | No. 2211 |   | ||||
| C00033819   | Epidihydrophaseic acid | No. 2610 | No. 38 |   | ||||
| C00002698   | Piceol / p-Hydroxyacetophenone / 4'-Hydroxyacetophenone | CHEMBL201083 | C031335 | 5 / 3 / 3 | No. 2849 |   | ||
| C00033557   | 3,4'-Dihydroxypropiophenone | CHEMBL1417159 | 25 / 10 / 7 | No. 2849 |   | |||
| C00029477   | beta-Hydroxypropiovanillone / omega-Hydroxypropioguaiacone / 3,4'-Dihydroxy-3'-methoxypropiophenone / 3-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-1-propanone | CHEMBL485875 | No. 2959 |   | ||||
| C00033738   | C-veratroylglycol | CHEMBL590536 | No. 2959 |   | ||||
| C00030712   | Dianthoside / (-)-Dianthoside / Maltol glucoside / Maltol beta-D-glucopyranoside | CHEMBL485278 | No. 3335 |   | ||||
| C00033589   | 7-Octene-1,6-diol | No. 3536 |   | |||||
| C00033511   | 1-(3,4-Dimethoxyphenyl)-1,3-propanediol | No. 5078 |   | |||||
| C00031831   | Grasshopper ketone / (-)-Grasshopper ketone | CHEMBL456946 | No. 5414 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P43166 | Carbonic anhydrase 7 | Lyase | C00000856 C00002743 C00029479 C00033837 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00002743 C00002783 C00033685 C00033686 | 0 / 0 | 
| Q16790 | Carbonic anhydrase 9 | Lyase | C00000856 C00002743 C00029479 C00033837 | 0 / 1 | 
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000856 C00002743 C00029479 C00033837 | 0 / 0 | 
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000982 C00002728 C00002743 C00029961 | 1 / 1 | 
| O43570 | Carbonic anhydrase 12 | Lyase | C00000856 C00002743 C00029479 C00033837 | 1 / 2 | 
| P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000856 C00002683 C00002698 C00033837 | 0 / 0 | 
| O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000856 C00002683 C00002698 C00033837 | 0 / 0 | 
| P00915 | Carbonic anhydrase 1 | Lyase | C00000856 C00002743 C00029479 C00033837 | 0 / 0 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00000856 C00002743 C00029479 C00033837 | 1 / 2 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000982 C00002743 C00033556 C00033686 | 0 / 3 | 
| P22748 | Carbonic anhydrase 4 | Lyase | C00000856 C00002743 C00029479 | 1 / 1 | 
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000856 C00000982 C00002683 | 0 / 0 | 
| P10275 | Androgen receptor | NR3C4 | C00000982 C00002683 C00033837 | 3 / 4 | 
| P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00000856 C00002683 C00002698 | 1 / 1 | 
| O75496 | Geminin | Unclassified protein | C00000982 C00002743 C00002783 | 0 / 0 | 
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000982 C00002743 C00033837 | 5 / 1 | 
| P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00000856 C00002683 C00002698 | 1 / 1 | 
| Q9UNA4 | DNA polymerase iota | Enzyme | C00000982 C00002783 C00033557 | 0 / 0 | 
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000982 C00029961 C00033999 | 0 / 0 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000982 C00002683 C00033557 | 1 / 1 | 
| P03372 | Estrogen receptor | NR3A1 | C00000982 C00002743 C00029961 | 1 / 1 | 
| P23280 | Carbonic anhydrase 6 | Lyase | C00000856 C00002743 C00029479 | 0 / 0 | 
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002683 C00002783 C00033557 | 0 / 0 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000982 C00002743 | 0 / 0 | 
| Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000856 C00002743 | 0 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00000982 C00002743 | 1 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000982 C00002743 | 0 / 0 | 
| P51580 | Thiopurine S-methyltransferase | Enzyme | C00000856 C00029479 | 1 / 1 | 
| P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000856 C00002743 | 0 / 0 | 
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000856 C00000982 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000982 C00002743 | 1 / 1 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000982 C00002743 | 0 / 0 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000982 C00002743 | 0 / 1 | 
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00002783 C00033557 | 0 / 0 | 
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002683 C00033837 | 0 / 0 | 
| P07451 | Carbonic anhydrase 3 | Lyase | C00000856 C00002743 | 0 / 0 | 
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00000982 C00033686 | 2 / 2 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00000982 C00002743 | 0 / 1 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002783 C00033557 | 0 / 0 | 
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00002783 C00033557 | 0 / 0 | 
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00002783 C00033557 | 0 / 0 | 
| P15121 | Aldose reductase | Enzyme | C00000982 C00029961 | 0 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00000982 C00002743 | 0 / 1 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000982 C00002743 | 0 / 0 | 
| P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00002683 C00002743 | 0 / 0 | 
| P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000982 C00002743 | 0 / 0 | 
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002783 C00033557 | 0 / 0 | 
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002743 C00033557 | 0 / 0 | 
| P39748 | Flap endonuclease 1 | Enzyme | C00002783 C00033557 | 0 / 0 | 
| Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00002743 C00029961 | 0 / 0 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002783 C00033557 | 0 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000982 C00002743 | 0 / 1 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002683 C00033557 | 0 / 0 | 
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000982 C00002743 | 3 / 0 | 
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000982 C00002743 | 1 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000982 C00002743 | 0 / 0 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000856 C00002743 | 1 / 8 | 
| Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00000856 C00002683 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002743 | 0 / 0 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00002743 | 2 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002743 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002743 | 0 / 0 | 
| P54132 | Bloom syndrome protein | Enzyme | C00033557 | 1 / 2 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002743 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00002743 | 0 / 0 | 
| O75828 | Carbonyl reductase [NADPH] 3 | Enzyme | C00000982 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002743 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002743 | 1 / 1 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002743 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002743 | 1 / 0 | 
| P24864 | G1/S-specific cyclin-E1 | Other cytosolic protein | C00000982 | 0 / 2 | 
| P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00000982 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002743 | 0 / 0 | 
| P04278 | Sex hormone-binding globulin | Secreted protein | C00000982 | 0 / 0 | 
| P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00000982 | 1 / 1 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002743 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00002743 | 0 / 0 | 
| Q9UQ49 | Sialidase-3 | Enzyme | C00000856 | 0 / 0 | 
| P16152 | Carbonyl reductase [NADPH] 1 | Enzyme | C00000982 | 0 / 0 | 
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00029479 | 2 / 0 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002743 | 0 / 0 | 
| P08183 | Multidrug resistance protein 1 | drug | C00000982 | 1 / 0 | 
| P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00000982 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002743 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00002743 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00002743 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00002743 | 1 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002743 | 0 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002743 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00002743 | 0 / 0 | 
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00033557 | 1 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002743 | 1 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002743 | 1 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002743 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00002743 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002743 | 1 / 0 | 
| O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00002683 | 0 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00002743 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002743 | 0 / 0 | 
| Q9Y253 | DNA polymerase eta | Enzyme | C00033557 | 1 / 1 | 
| P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00033557 | 0 / 0 | 
| P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00033557 | 3 / 1 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00002743 | 0 / 0 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00002743 | 0 / 0 | 
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00000982 | 1 / 0 | 
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000982 | 0 / 0 | 
| P00734 | Prothrombin | S1A | C00033999 | 4 / 2 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002743 | 1 / 1 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002743 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002743 | 0 / 0 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 1 | 
| P14679 | Tyrosinase | Oxidoreductase | C00002743 | 4 / 2 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002743 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002743 | 2 / 0 | 
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00000982 | 5 / 3 | 
| P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002683 | 0 / 0 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002743 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002743 | 1 / 0 | 
| Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00000982 | 4 / 4 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00002743 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002743 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002743 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002743 | 0 / 0 | 
| P04745 | Alpha-amylase 1 | Enzyme | C00000982 | 0 / 0 | 
| P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00000982 | 2 / 0 | 
| Q96RI1 | Bile acid receptor | NR1H4 | C00002683 | 0 / 0 | 
| P37058 | Testosterone 17-beta-dehydrogenase 3 | Enzyme | C00002698 | 1 / 1 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002743 | 1 / 0 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00002743 | 0 / 0 | 
| P10696 | Alkaline phosphatase, placental-like | Enzyme | C00033557 | 0 / 1 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002743 | 2 / 1 | 
| P62158 | Calmodulin | Unclassified protein | C00000982 | 1 / 0 | 
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00033557 | 0 / 0 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000982 | 3 / 3 | 
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00000982 | 2 / 0 | 
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00000982 | 1 / 1 | 
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002683 | 2 / 2 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00002743 | 2 / 2 | 
| Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00002683 | 0 / 0 | 
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000982 | 0 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00002743 | 0 / 0 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002743 | 1 / 0 | 
| P29466 | Caspase-1 | C14 | C00002743 | 0 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002743 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002743 | 0 / 0 | 
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00033557 | 1 / 1 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002743 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00002743 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00002743 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002743 | 0 / 0 | 
| P04062 | Glucosylceramidase | Enzyme | C00000982 | 6 / 4 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002743 | 0 / 0 | 
| P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00000982 | 0 / 0 | 
| P06746 | DNA polymerase beta | Enzyme | C00033557 | 0 / 0 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002743 | 0 / 0 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002743 | 0 / 0 | 
| Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002743 | 3 / 0 | 
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00033557 | 0 / 0 | 
| P78527 | DNA-dependent protein kinase catalytic subunit | Atypical serine/threonine protein kinase PIKK subfamily | C00002683 | 0 / 0 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00002743 | 0 / 0 | 
| P08246 | Neutrophil elastase | S1A | C00002743 | 2 / 1 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002743 | 2 / 2 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002743 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00002743 | 0 / 0 | 
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00000982 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002743 | 1 / 1 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002743 | 0 / 0 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00002743 | 0 / 1 | 
| Q04760 | Lactoylglutathione lyase | Enzyme | C00000982 | 0 / 0 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002743 | 0 / 0 | 
| P49888 | Estrogen sulfotransferase | Enzyme | C00000982 | 0 / 0 | 
| Q99700 | Ataxin-2 | Unclassified protein | C00002783 | 1 / 1 | 
| Q12794 | Hyaluronidase-1 | Enzyme | C00002743 | 1 / 2 | 
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000982 | 0 / 0 | 
| Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00000982 | 1 / 0 | 
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00033557 | 0 / 0 | 
| Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00033557 | 0 / 0 | 
| P33527 | Multidrug resistance-associated protein 1 | drugs | C00000982 | 0 / 0 | 
| O00255 | Menin | Unclassified protein | C00000982 | 2 / 5 | 
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000982 | 1 / 2 | 
| P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00000982 | 0 / 0 | 
| Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00033557 | 2 / 1 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) | C00002743
                          C00029961
                          C00033837 | 
| 54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | C00000982
                          C00002743
                          C00029961 | 
| 54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) | C00000982
                          C00002743
                          C00029961 | 
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | C00000982
                          C00002743
                          C00002783 | 
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | C00000982
                          C00002743
                          C00029961 | 
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor | C00000982
                          C00002783 | 
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) | C00002743
                          C00002783 | 
| 3952 | LEP, LEPD, OB, OBS | leptin | C00000856
                          C00033837 | 
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | C00002743
                          C00002783 | 
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 | C00002743
                          C00002783 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00000982
                          C00002783 | 
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) | C00002743
                          C00002783 | 
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | C00000982
                          C00002743 | 
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) | C00002743
                          C00029961 | 
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | C00002743
                          C00002783 | 
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 | C00002743
                          C00002783 | 
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) | C00000856
                          C00000982 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00000982
                          C00002783 | 
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) | C00000982
                          C00033837 | 
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 | C00000982
                          C00033837 | 
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | C00000982
                          C00029961 | 
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | C00000982
                          C00029961 | 
| 405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator | C00000982
                          C00002783 | 
| 23621 | BACE1, ASP2, BACE, HSPC104 | beta-site APP-cleaving enzyme 1 (EC:3.4.23.46) | C00002743 | 
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | C00000982 | 
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 | C00000982 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00000982 | 
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | C00000982 | 
| 1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | C00000982 | 
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | C00000982 | 
| 8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | C00000982 | 
| 1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) | C00000982 | 
| 249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) | C00000982 | 
| 10057 | ABCC5, ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | C00000982 | 
| 10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | C00000982 | 
| 3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 | C00000982 | 
| 5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) | C00000982 | 
| 6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 | C00000982 | 
| 6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 | C00000982 | 
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | C00000982 | 
| 6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) | C00000982 | 
| 6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) | C00002743 | 
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 | C00000982 | 
| 54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | C00000982 | 
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) | C00000982 | 
| 7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) | C00000982 | 
| 5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | C00002743 | 
| 1586 | CYP17A1, CPT7, CYP17, P450C17, S17AH | cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) | C00029961 | 
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) | C00029961 | 
| 1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | C00029961 | 
| 1558 | CYP2C8, CPC8, CYPIIC8, MP-12/MP-20 | cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) | C00029961 | 
| 1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | C00029961 | 
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) | C00029961 | 
| 338442 | HCAR2, GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g | hydroxycarboxylic acid receptor 2 | C00029961 | 
| 3284 | HSD3B2, HSD3B, HSDB, SDR11E2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) | C00029961 | 
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | C00029961 | 
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 | C00002783 | 
| 894 | CCND2, KIAK0002 | cyclin D2 | C00002783 | 
| 896 | CCND3 | cyclin D3 | C00002783 | 
| 898 | CCNE1, CCNE | cyclin E1 | C00002783 | 
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) | C00002783 | 
| 1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) | C00002783 | 
| 1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) | C00002783 | 
| 1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | C00002783 | 
| 3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 | C00002783 | 
| 1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 | C00002783 | 
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) | C00002783 | 
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 | C00002783 | 
| 3458 | IFNG, IFG, IFI | interferon, gamma | C00002783 | 
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) | C00002783 | 
| 3689 | ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | C00002783 | 
| 27035 | NOX1, GP91-2, MOX1, NOH-1, NOH1 | NADPH oxidase 1 | C00002783 | 
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | C00002783 | 
| 4087 | SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2 | SMAD family member 2 | C00002783 | 
| 4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 | C00002783 | 
| 6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) | C00002783 | 
| 7039 | TGFA, TFGA | transforming growth factor, alpha | C00002783 | 
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 | C00002783 | 
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 | C00002783 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #264300 | 17-beta hydroxysteroid dehydrogenase iii deficiency | P37058 | 
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #103470 | Albinism, ocular, with sensorineural deafness | P14679 | 
| #203100 | Albinism, oculocutaneous, type ia; oca1a | P14679 | 
| #606952 | Albinism, oculocutaneous, type ib; oca1b | P14679 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #300068 | Androgen insensitivity syndrome; ais | P10275 | 
| #312300 | Androgen insensitivity, partial; pais | P10275 | 
| #613546 | Aromatase deficiency | P11511 | 
| #139300 | Aromatase excess syndrome; aexs | P11511 | 
| #600807 | Asthma, susceptibility to | Q13093 | 
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 | P22309 | 
| #614490 | Blood group, junior system; jr | Q9UNQ0 | 
| #210900 | Bloom syndrome; blm | P54132 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| %606641 | Body mass index; bmi | P37231 | 
| #300615 | Brunner syndrome | P21397 | 
| #609338 | Carotid intimal medial thickness 1 | P37231 | 
| #114500 | Colorectal cancer; crc | P18054 P84022 Q14191 | 
| #218800 | Crigler-najjar syndrome, type i | P22309 P22310 | 
| #606785 | Crigler-najjar syndrome, type ii | P22309 P22310 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #119900 | Digital clubbing, isolated congenital | P15428 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #237500 | Dubin-johnson syndrome; djs | Q92887 | 
| #133239 | Esophageal cancer | P18054 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #613163 | Gaba-transaminase deficiency | P80404 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #608013 | Gaucher disease, perinatal lethal | P04062 | 
| #230800 | Gaucher disease, type i | P04062 | 
| #230900 | Gaucher disease, type ii | P04062 | 
| #231000 | Gaucher disease, type iii | P04062 | 
| #231005 | Gaucher disease, type iiic | P04062 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #143500 | Gilbert syndrome | P22309 P22310 | 
| #137750 | Glaucoma 1, open angle, a; glc1a | Q16678 | 
| #231300 | Glaucoma 3, primary congenital, a; glc3a | Q16678 | 
| #137760 | Glaucoma, primary open angle; poag | Q16678 | 
| #137800 | Glioma susceptibility 1; glm1 | P04626 P37231 | 
| #232300 | Glycogen storage disease ii | P10253 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #237450 | Hyperbilirubinemia, rotor type; hblrr | Q9NPD5 Q9Y6L6 | 
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn | P22309 | 
| #143860 | Hyperchlorhidrosis, isolated | O43570 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 | P15428 | 
| #146300 | Hypophosphatasia, adult | P05186 | 
| #241510 | Hypophosphatasia, childhood | P05186 | 
| #241500 | Hypophosphatasia, infantile | P05186 | 
| #147050 | Ige responsiveness, atopic; iger | Q13093 | 
| #612244 | Inflammatory bowel disease 13; ibd13 | P08183 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #601626 | Leukemia, acute myeloid; aml | P36888 | 
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 | P37231 | 
| #613795 | Loeys-dietz syndrome, type 3; lds3 | P84022 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #601492 | Mucopolysaccharidosis, type ix; mps9 | Q12794 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #160900 | Myotonic dystrophy 1; dm1 | Q9NR56 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #601665 | Obesity | P32245 P37231 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #168600 | Parkinson disease, late-onset; pd | P04062 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #604229 | Peters anomaly | Q16678 | 
| #614278 | Platelet-activating factor acetylhydrolase deficiency; pafad | Q13093 | 
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 | P00734 | 
| #613679 | Prothrombin deficiency, congenital | P00734 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #600852 | Retinitis pigmentosa 17; rp17 | P22748 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 | P14679 | 
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 | P10275 | 
| #183090 | Spinocerebellar ataxia 2; sca2 | Q99700 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #601367 | Stroke, ischemic | P00734 | 
| #271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd | P51649 | 
| #610460 | Thiopurine s-methyltransferase deficiency | P51580 | 
| #188050 | Thrombophilia due to thrombin defect; thph1 | P00734 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 | Q9UNQ0 | 
| #614916 | Ventricular tachycardia, catecholaminergic polymorphic, 4; cpvt4 | P62158 | 
| #277700 | Werner syndrome; wrn | Q14191 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #278300 | Xanthinuria, type i | P47989 | 
| #278750 | Xeroderma pigmentosum, variant type; xpv | Q9Y253 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H01302 | Hyperchlorhidrosis isolated (HCHLH) | O43570
                            (related) | 
| H00021 | Renal cell carcinoma | O43570
                            (marker) Q16790 (marker) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) P24864 (related) | 
| H00022 | Bladder cancer | P00533
                            (related) P04626 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) P24864 (related) | 
| H00223 | Inherited thrombophilia | P00734
                            (related) | 
| H01254 | Congenital prothrombin deficiency | P00734
                            (related) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) Q92731 (marker) | 
| H00066 | Lewy body dementia (LBD) | P04062
                            (related) | 
| H00126 | Gaucher disease | P04062
                            (related) | 
| H00426 | Defects in the degradation of ganglioside | P04062
                            (related) | 
| H00810 | Progressive myoclonic epilepsy (PME) | P04062
                            (related) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) P11511 (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) | 
| H00027 | Ovarian cancer | P04626
                            (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P35354 (related) | 
| H00213 | Hypophosphatasia | P05186
                            (related) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00069 | Glycogen storage diseases (GSD) | P10253
                            (related) | 
| H00024 | Prostate cancer | P10275
                            (related) | 
| H00062 | Spinal and bulbar muscular atrophy (SBMA) | P10275
                            (related) | 
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) | P10275
                            (related) P37058 (related) | 
| H00609 | 46,XY disorders of sex development (Other) | P10275
                            (related) | 
| H00023 | Testicular cancer | P10696
                            (marker) | 
| H00794 | Aromatase excess syndrome | P11511
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00168 | Oculocutaneous albinism (OCA) | P14679
                            (related) | 
| H00038 | Malignant melanoma | P14679
                            (marker) | 
| H00025 | Penile cancer | P14780
                            (related) P35354 (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00457 | Primary hypertrophic osteoarthropathy (PHO) | P15428
                            (related) | 
| H01246 | Isolated congenital nail clubbing (ICNC) | P15428
                            (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H00208 | Hyperbilirubinemia | P22309
                            (related) Q92887 (related) | 
| H00527 | Retinitis pigmentosa (RP) | P22748
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00003 | Acute myeloid leukemia (AML) | P36888
                            (related) | 
| H00032 | Thyroid cancer | P37231
                            (related) | 
| H00409 | Type II diabetes mellitus | P37231
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P37231
                            (related) | 
| H00192 | Xanthinuria | P47989
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) Q99714 (related) | 
| H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) | P51580
                            (related) | 
| H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency | P51649
                            (related) | 
| H00094 | DNA repair defects | P54132
                            (related) | 
| H00296 | Defects in RecQ helicases | P54132
                            (related) Q14191 (related) | 
| H01257 | GABA-transaminase deficiency | P80404
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q03164
                            (related) Q03164 (marker) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00133 | Mucopolysaccharidosis type IX (MPS9) | Q12794
                            (related) | 
| H00421 | Mucopolysaccharidosis (MPS) | Q12794
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00612 | Primary open angle glaucoma | Q16678
                            (related) | 
| H01075 | Peters anomaly | Q16678
                            (related) | 
| H01159 | Anterior segment dysgenesis (ASD) | Q16678
                            (related) | 
| H01203 | Primary congenital glaucoma (PCG) | Q16678
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q99700
                            (related) Q9NUW8 (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) | 
| H00403 | Disorders of nucleotide excision repair | Q9Y253
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D008545 | Melanoma | C00002743 C00033837 C00029961 | 
| D007249 | Inflammation | C00002743 C00002783 | 
| D008106 | Liver Cirrhosis, Experimental | C00002743 C00000982 | 
| D056486 | Drug-Induced Liver Injury | C00000982 | 
| D002252 | Carbon Tetrachloride Poisoning | C00002743 | 
| D009203 | Myocardial Infarction | C00002743 | 
| D000647 | Amnesia | C00000982 | 
| D001932 | Brain Neoplasms | C00000982 | 
| D009202 | Cardiomyopathies | C00000982 | 
| D050197 | Atherosclerosis | C00002743 | 
| D064420 | Drug-Related Side Effects and Adverse Reactions | C00000982 | 
| D007674 | Kidney Diseases | C00000982 | 
| D008107 | Liver Diseases | C00000982 | 
| D009369 | Neoplasms | C00000982 | 
| D009374 | Neoplasms, Experimental | C00000982 | 
| D003384 | Coxsackievirus Infections | C00029961 | 
| D012220 | Rhinitis | C00000856 | 
| D007938 | Leukemia | C00002783 | 
| D014947 | Wounds and Injuries | C00002783 |